Ana Marina Rodriguez

Dr. Ana Marina Rodriguez

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Papillomavirus Research
Verified
Journal Article
Open access
SKSapna Kaul
Sapna Kaul
TDThuy Quynh N. Do
Thuy Quynh N. Do
EHEnshuo Hsu
Enshuo Hsu
KSKathleen M. Schmeler
Kathleen M. Schmeler
JMJane R. Montealegre
Jane R. Montealegre
ARAna Marina Rodriguez
Ana Marina Rodriguez
Compare the effectiveness of community-based HPV-related education and onsite school-based vaccination versus community-based education only for increasing HPV vaccine uptake in a rural, medically underserved area. Our cohort included 2307 Rio Grande City Consolidated Independent School District (RGCISD) middle school students from 3 schools enrolled in August 2016 and followed until April 2018. Using a quasi-experimental design, this study implemented an onsite school-based vaccination program and physician-led education on HPV and HPV vaccines for parents/guardians, school nurses/staff, and pediatric/family providers in the surrounding community (15-mile radius of RGCCISD) at 1 middle school ("intervention school"), and education-only for the remaining 2 schools ("comparison schools"). The Centers for Disease Control and Prevention's HPV-related educational materials supplemented the education. HPV vaccine status was obtained from school immunization records and the project's contracted vaccine vendor. HPV vaccine initiation and completion rates were compared pre and post intervention and between the intervention and comparison schools. Logistic regression was used to compare the odds of newly initiating/completing vaccination between the intervention and comparison schools. At baseline, the intervention school had lower HPV vaccine initiation and completion rates than the comparison schools (20.00% and 8.70% vs 28.97% and 14.56%). Post intervention, the intervention school had higher initiation and completion rates than the comparison schools (53.67% and 28.36% vs 41.56% and 20.53%). Students from the intervention school were over 3.6-times more likely to newly initiate/complete the HPV vaccinations than students from the comparison schools. The school with on-site vaccination events and community-based education had a higher adolescent HPV vaccination rate compared to schools that received community-based education only.

1 April 2019 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
ARAna Marina Rodriguez
Ana Marina Rodriguez
TDThuy Quynh N. Do
Thuy Quynh N. Do
MGMichael Goodman
Michael Goodman
KSKathleen M. Schmeler
Kathleen M. Schmeler
SKSapna Kaul
Sapna Kaul
YKYong-Fang Kuo
Yong-Fang Kuo

10 February 2020 in Cancer
Verified
Journal Article
Closed access
PDF file
ARAna Marina Rodriguez
Ana Marina Rodriguez
BZBurak Zeybek
Burak Zeybek
MVMicah Vaughn
Micah Vaughn
JWJordan Westra
Jordan Westra
SKSapna Kaul
Sapna Kaul
YKYong‐Fang Kuo
Yong‐Fang Kuo

26 June 2019 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
MVMelissa Victory
Melissa Victory
TDThuy Quynh N. Do
Thuy Quynh N. Do
YKYong-Fang Kuo
Yong-Fang Kuo
ARAna Marina Rodriguez
Ana Marina Rodriguez
Purpose: Despite its availability for more than a decade, the human papillomavirus (HPV) vaccine has low uptake in Texas (49%). The objective of this study was to understand parental knowledge and attitudes about HPV and the HPV vaccine as well as child experience with the HPV vaccine among a medically underserved, economically disadvantaged population. Methods: As part of a Cancer Prevention Research Institute of Texas-funded project to improve HPV vaccination rates, we surveyed parents / guardians of 4th–12th graders (ages 9–17) in the Rio Grande City Consolidated Independent School District (RGCCISD). Descriptive statistics were used to describe parents’ knowledge and attitude and children’s vaccine experience. Results: Of the7,055 surveys distributed, 622 (8.8%) were returned. About 84% of the respondents were female. About 57.1% of the parents /guardians had female RGCCISD students with a mean age of 11.7 ± 1.8 years. Overall, 43.9% reported receiving a healthcare provider recommendation and 32.5% had their child vaccinated. Higher percentages were reported if the respondent was female and had a female child aged ≥ 15 years old. Among survey respondents, 28.2% reported their child initiated the HPV vaccine and 18.8% completed the series. Barriers of uptake included work / school schedule conflicts and no healthcare provider recommendation. Conclusions: There are still prominent gaps in parents’ and students’ complete understanding of HPV vaccination, n, gender preferences for vaccination, and provider recommendations. Future interventions must target men and minority populations in order to increase knowledge and awareness about HPV, the HPV vaccine, and HPV-associated cancers.

1 December 2014 in Gynecologic Oncology
Verified
Journal Article
Closed access
ARAna Marina Rodriguez
Ana Marina Rodriguez
KSKathleen M. Schmeler
Kathleen M. Schmeler
YKYong_Fang Kuo
Yong_Fang Kuo

3 April 2014 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
ARAna Marina Rodriguez
Ana Marina Rodriguez
YKYong-Fang Kuo
Yong-Fang Kuo
JGJames S. Goodwin
James S. Goodwin